Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. 10x Genomics, Inc.
  6. News
  7. Summary
    TXG   US88025U1097

10X GENOMICS, INC.

(TXG)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
48.65 USD   +1.29%
01/1910x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023
PR
01/09Transcript : 10x Genomics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-08-2023 through Jan-12-2023
CI
01/05Cornell University : Method precisely locates gene activity and proteins across tissues
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about 10X GENOMICS, INC.
01/1910x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February ..
PR
01/09Transcript : 10x Genomics, Inc. Presents at 41st Annual J.P. Morgan Healthcar..
CI
01/05Cornell University : Method precisely locates gene activity and proteins across tissues
AQ
202210x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR
2022Deutsche Bank Initiates Coverage on 10x Genomics With Buy Rating, $50 Price Target
MT
202210x Genomics : Investor Day Presentation
PU
202210x Genomics Commercially Launches Xenium Platform for In Situ Analysis
PR
202210x Genomics, Inc. Launches Xenium Platform for In Situ Analysis
CI
2022Transcript : 10x Genomics, Inc. - Analyst/Investor Day
CI
2022Jumpcode Genomics Joins 10x Genomics' Compatible Partner Program (CPP)
AQ
2022Sector Update: Health Care Stocks Tracking Higher on Thursday
MT
2022Sector Update: Health Care
MT
202210x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Disco..
PR
202210X Genomics, Inc. Announces Commercial Availability of BEAM
CI
2022Morgan Stanley Adjusts Price Target on 10x Genomics to $64 From $70, Maintains Overweig..
MT
More most relevant news
All news about 10X GENOMICS, INC.
01/1910x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February ..
PR
01/09Transcript : 10x Genomics, Inc. Presents at 41st Annual J.P. Morgan Healthcar..
CI
01/05Cornell University : Method precisely locates gene activity and proteins across tissues
AQ
202210x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR
2022Cancer researchers question antitrust arguments against Illumina-Grail deal
RE
2022Deutsche Bank Initiates Coverage on 10x Genomics With Buy Rating, $50 Price Target
MT
202210x Genomics : Investor Day Presentation
PU
202210x Genomics Commercially Launches Xenium Platform for In Situ Analysis
PR
202210x Genomics, Inc. Launches Xenium Platform for In Situ Analysis
CI
2022Transcript : 10x Genomics, Inc. - Analyst/Investor Day
CI
More news
News in other languages on 10X GENOMICS, INC.
202210x Genomics, Inc. Lance la plateforme Xenium pour l'analyse in situ
2022Mise à jour sectorielle : Les actions du secteur de la santé por..
2022Mise à jour sectorielle : Les actions du secteur de la santé sui..
2022Mise à jour sectorielle : Soins de santé
202210X Genomics, Inc. annonce la disponibilité commerciale de BEAM
202210x Genomics, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois t..
202210X Genomics, Inc. Fournit des prévisions de revenus pour l'ensemble de l'année 2022
2022Oxford Nanopore Technologies annonce une nouvelle collaboration avec 10X Genomics pour ..
2022Mise à jour sectorielle : Les actions du secteur de la santé ne ..
2022Mise à jour sectorielle : Les actions du secteur de la santé rec..
More news
Analyst Recommendations on 10X GENOMICS, INC.
2022Deutsche Bank Initiates Coverage on 10x Genomics With Buy Rating, $50 Price Target
MT
2022Morgan Stanley Adjusts Price Target on 10x Genomics to $64 From $70, Maintains Overweig..
MT
2022Goldman Sachs Lowers Price Target on 10x Genomics to $25 From $35, Maintains Sell Ratin..
MT
2022Goldman Sachs Downgrades 10x Genomics to Sell From Neutral, Lowers Price Target to $35 ..
MT
2022Morgan Stanley Adjusts 10x Genomics' Price Target to $70 from $100, Keeps Overweight Ra..
MT
More recommendations
Press releases
01/1910x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February ..
PR
01/05Cornell University : Method precisely locates gene activity and proteins across tissues
AQ
202210x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
PR
202210x Genomics : Investor Day Presentation
PU
202210x Genomics Commercially Launches Xenium Platform for In Situ Analysis
PR
More press releases
Upcoming event on 10X GENOMICS, INC.
02/15/23FY 2022 Earnings Call
Upcoming sector events
03/01/23BIOMÉRIEUX : FY 2022 Earnings Release (Projected)
03/08/23DIASORIN S.P.A. : FY 2022 Earnings Release (Projected)
04/07/23SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. : FY 2022 Earnings Release
04/21/23AUTOBIO DIAGNOSTICS CO., LTD. : FY 2022 Earnings Release
Sector
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Diagnostic & Testing Substances